Healthcare -
Biotechnology - NASDAQ - US
$ 1.32
6.3 %
$ 841 M
Market Cap
-5.0
P/E
GERN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities GERN - Geron Corporation
334 M
LAST VALUE
95.75%
2 YEAR CAGR
76.54%
5 YEAR CAGR
13.02%
10 YEAR CAGR